How Much Did Genome Medical Raise?
Funding & Key Investors

Genome Medical has established itself as a pivotal player in the digital health landscape, securing significant capital to advance its telehealth-based clinical practice. With a total funding trajectory reaching $120M, the company has successfully navigated multiple rounds of financing, culminating in a major strategic investment of $60M. This capital infusion underscores the market's confidence in the firm's ability to integrate genomics and long-distance clinical care into the modern healthcare infrastructure.

The company's growth trajectory, marked by consistent backing from top-tier institutional investors, reflects its transition from an early-stage innovator to a mature enterprise-level entity. By leveraging advanced communication technologies—including video, secure messaging, and shared imaging—Genome Medical is effectively bridging the gap between complex genetic insights and actionable patient care.

What is Genome Medical?

Genome Medical
Hospitals & Physicians ClinicsMedical Practice ManagementHealthcare Services

Headquartered in South San Francisco, Genome Medical operates as a comprehensive telehealth platform dedicated to the promotion and delivery of clinical health services. The company specializes in providing professional health-related education and administrative support, utilizing a robust digital framework to facilitate remote consultations. By positioning itself at the intersection of precision medicine and accessible healthcare, the firm addresses critical gaps in the current medical delivery system, ensuring that patients and providers can collaborate seamlessly regardless of geographic constraints.

How much funding has Genome Medical raised?

Genome Medical has raised a total of $120M across 3 funding rounds:

2017

Series A

$23M

2020

Series B

$37M

2021

Series C

$60M

Series A (2017): $23M with participation from Canaan Partners, HealthInvest Equity Partners, Illumina Ventures, and Flywheel Ventures

Series B (2020): $37M led by Perceptive Advisors, Dreamers Fund, Canaan Partners, Manatt Venture Fund, Randy Scott, Casdin Capital, Samsung Electronics America, Kaiser Permanente Ventures, LRVHealth, Avestria Ventures, Echo Health Ventures, Revelation Partners, HealthInvest Equity Partners, Illumina Ventures, Flywheel Ventures, and GE Ventures

Series C (2021): $60M supported by Amgen Ventures, Canaan Partners, Casdin Capital, GV, Kaiser Permanente Ventures, and Perceptive Advisors

Key Investors in Genome Medical

Canaan Partners

Canaan Partners is a venture capital firm specializing in early-stage investments across technology and healthcare, with a strong focus on digital health and biopharma innovation.

Casdin Capital

Casdin Capital is an investment firm that brings deep expertise to the life sciences sector, specifically targeting diagnostics and molecular information pioneers.

Kaiser Permanente Ventures

Kaiser Permanente Ventures is a strategic investment arm focused on advancing healthcare innovation by partnering with entrepreneurs to build solutions that provide clear value for providers and patients.

What's next for Genome Medical?

Looking ahead, the strategic deployment of $60M is expected to accelerate the scaling of Genome Medical's clinical operations and technological capabilities. As the firm continues to mature, the focus will likely shift toward deepening its integration within established healthcare delivery systems and expanding its footprint in the genomics sector. The continued support from institutional partners suggests a long-term commitment to driving systemic healthcare transformation, with an emphasis on sustainable growth and the widespread adoption of precision health solutions in both clinical and research environments.

See full Genome Medical company page
See More Financial Insights
No matching results.
Refine your search.

Additional financial insights in the Hospitals & Physicians Clinics industry

Hospitals & Physicians ClinicsPhysicians ClinicsMedical Practice Management
Hospitals & Physicians ClinicsMedical Practice ManagementHealthcare ServicesMental Health & Rehabilitation Facilities
Hospitals & Physicians ClinicsPhysicians Clinics
Hospitals & Physicians ClinicsPhysicians ClinicsMedical Practice Management

Frequently Asked Questions Regarding Genome Medical Financial Insights

What are the most recent funding rounds that Genome Medical has completed, and what were the funding rounds?
Genome Medical has recently completed 3 funding rounds: Series C on Aug 30, 2021, Series B on Jul 1, 2020, Series A on May 29, 2017.
What is the total amount of funding Genome Medical has raised to date?
Genome Medical has raised a total of $120M in funding to date.
How many funding rounds has Genome Medical completed?
Genome Medical has completed 3 funding rounds.
How much funding did Genome Medical raise in its most recent funding round?
Genome Medical raised $60M in its most recent funding round.
Who are the lead investors in Genome Medical's latest funding round?
The lead investor in Genome Medical's latest funding round was Amgen Ventures. To access investor data and explore similar companies, sign up for ZoomInfo.
Which was the largest funding round in Genome Medical's history?
The largest funding round in Genome Medical's history was $60M.
See more information about Genome Medical